Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib (Q34572719)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib |
scientific article |
Statements
1 reference
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib (English)
1 reference
Anjali Singh
1 reference
Xueqing Lun
1 reference
Aarthi Jayanthan
1 reference
Halah Obaid
1 reference
Yibing Ruan
1 reference
Douglas Strother
1 reference
Susan N Chi
1 reference
Amy Smith
1 reference
Peter Forsyth
1 reference
Aru Narendran
1 reference
11 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference